Lung cancer is one of the leading causes of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases. http://visualvistaventures.weebly.com/insightsmarketer/non-small-cell-lung-cancer-therapeutics-market-primed-for-growth-with-immuno-oncology-trend